Fasting and medical issues during Ramadan [3]

JAMA

Volumn 294, Issue 13, 2005, Pages 1618-

  Crosby, Sondra S ^a   Rourke, Elizabeth J ^b   Warfa, Mohamed A ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MOSLEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RELIGION; RISK ASSESSMENT;

EID: 26044465818     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.13.1618-a     Document Type: Letter

References (5)

1. Population Reference Bureau. How Many Muslims Live in the United States? Available at: http://www.prb.org/Content/NavigationMenu/PRB/Journalists /PressReleases/How_Many_Muslims_Live_in_the_United_States_( January_2003).htm. Accessed September 5, 2005.
2. Salti I, Bénard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDAR) study. Diabetes Care. 2004;27:2306-2311.
3. Belkhadir J, El Ghomari H, Klocker N, et al. Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide. BMJ. 1993;307:292-295.
4. Omar MA, Motala AA. Fasting in Ramadan and the diabetic patient. Diabetes Care. 1997;20:1925-1926.
5. Kadiri A, Al-Nakhi A, El-Ghazali S, et al. Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab. 2001;27:482-486.